Skip to content

Observation on the Effect of Nalbuphine and Esketamine on Postoperative Emergence Agitation Following Tonsillectomy and Adenoidectomy in Preschool Children

Observation on the Effect of Nalbuphine and Esketamine on Postoperative Emergence Agitation Following Tonsillectomy and Adenoidectomy in Preschool Children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108572
Enrollment
Unknown
Registered
2025-09-01
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergence Agitation

Interventions

E Group:Esketamine 0.25 mg/kg was intravenously injected 10 minutes before the end of the surgery.
N1 Group:Nalbuphine 0.1 mg/kg was intravenously injected 10 minutes before the end of the surgery.
N2 Group:Nalbuphine 0.2 mg/kg was intravenously injected 10 minutes before the end of the surgery.

Sponsors

Shiyan People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 7 Years

Inclusion criteria

Inclusion criteria: Children aged 3 to 7 years scheduled for elective adenotonsillectomy under general anesthesia were screened for eligibility. Inclusion criteria included American Society of Anesthesiologists (ASA) physical status I or II and a body mass index (BMI) between 12 and 24 kg/m^2

Exclusion criteria

Exclusion criteria: Exclusion criteria comprised known cardiovascular or pulmonary disease, a history of neurological or psychiatric disorders, allergy to any study drugs or anesthetic agents, recent upper respiratory tract infection, precious airway surgery, refusal of parental consent, or any intraoperative or postoperative event requiring deviation from the study protocol

Design outcomes

Primary

MeasureTime frame
The incidence of emergence agitation;

Secondary

MeasureTime frame
PAED score;

Countries

China

Contacts

Public ContactZhangcheng Zou

Shiyan People's Hospital

2294195012@qq.com+86 189 7138 8520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026